MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multidisciplinary Approach"

  • 2022 International Congress

    Deep learning applied to retinal OCT images to differentiate Parkinson’s disease patients from healthy controls

    M. Barrenechea, D. Romero-Bascones, A. Murueta-Goyena, JC. Gomez-Esteban, A. Alberdi, A. Erramuzpe, U. Ayala, I. Gabilondo (Mondragon, Spain)

    Objective: This study aims to investigate the capability of artificial intelligence, more precisely deep convolutional neural networks (CNN), to automatically classify between healthy controls (HC)…
  • 2022 International Congress

    It takes a village: An interdisciplinary care model for atypical Parkinsonism

    H. Glover, J. Shurer, M. Ivancic, M. Sklerov (Chapel Hill, USA)

    Objective: To describe one interdisciplinary clinic designed to offer comprehensive care to patients with atypical parkinsonism syndromes, and to share the lessons learned which may…
  • 2022 International Congress

    Nutritional Status of Patients with Parkinson’s Disease: Report from Indonesian Tertiary Referral Hospital

    SS. Musthafa, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: This study aimed to describe and determine the prevalence of nutritional status in outpatient Parkinson’s Disease (PD) patients. Background: Parkinson’s disease is the most…
  • 2022 International Congress

    Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research

    K. Schroeder, C. Gallagher, M. Armstrong, M. Carnie, C. Evers, J. Fleisher, B. Kluger, J. Lamb, S. Seshadri, L. Wilson, M. Feeney, P. Davies (New York, USA)

    Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…
  • 2022 International Congress

    The phenomenon of unexpectedly high functional mobility in people with typical Parkinson’s disease. A cross-sectional data analysis.

    A-M. Hanff, C. Mccrum, G. Aguayo, A. Rauschenberger, A. Leist, R. Krüger, M. Zeegers (Strassen, Luxembourg)

    Objective: To describe the frequency of people with typical Parkinson’s disease (PD) with unexpectedly high functional mobility (a high functional mobility despite the presence of…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • 2022 International Congress

    Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital

    DA. Soraya, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…
  • 2022 International Congress

    Involving people with lived experience of Parkinson’s in trial design: the EJS ACT-PD initiative

    M-L. Zeissler, N. Bakshi, M. Bartlett, A. Batla, D. Byrom, R. Chapman, E. Deeson, R. Ellis-Doyle, C. Gonzales-Robles, A. Jewell, H. Matthews, L. Miller, G. Mills, L. Mooney, A. Morgan, J. Rudiger, D. Salathiel, P. Scurfield, C. Siu, S. Whipps, S. Wonnacott, T. Foltynie, C. Carroll, K. Mcfarthing (Plymouth, United Kingdom)

    Objective: To maximally involve people with the lived experience of Parkinson’s in the design of the first multi-arm multi-stage (MAMS) trial for disease modifying therapies…
  • MDS Virtual Congress 2021

    Intensive rehabilitation program for patients with functional motor disorders: 3-years’ experience.

    B. Martín Rojo, L. Martínez López, P. Rada Romero, C. Vicente Torcal, M. García Ibañez, B. Borda Nuin, M. Sanz Amador, C. Delgado Suarez, M. Kurtis Urra, I. Pareés Moreno (Madrid, Spain)

    Objective: To describe the clinical characteristics and the outcomes of a cohort of patients with functional movement disorders (FMD) who attended the FMD clinic of…
  • MDS Virtual Congress 2021

    Dance for Movement Disorders: Improving Health and Quality of Life

    K. Mason, D. Leventhal, J. Sonke, J. Langley, B. Whiteside, T. Gyang, B. Borgert, E. Johnson, D. Riley, C. Cassidy, L. Sinclair (Gainesville, USA)

    Objective: This poster will present four programs – the pioneering work of a dance for PD program, along with three programs that drew upon this…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley